SIPONIMOD for Relapsing-remitting multiple sclerosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 519 adverse event reports in the FDA FAERS database where SIPONIMOD was used for Relapsing-remitting multiple sclerosis.
Most Reported Side Effects for SIPONIMOD
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Fatigue | 958 | 11.2% | 4 | 133 |
| Headache | 862 | 10.1% | 0 | 89 |
| Dizziness | 654 | 7.6% | 5 | 75 |
| Gait disturbance | 506 | 5.9% | 1 | 109 |
| Multiple sclerosis relapse | 504 | 5.9% | 4 | 132 |
| Fall | 478 | 5.6% | 4 | 166 |
| Multiple sclerosis | 455 | 5.3% | 11 | 85 |
| Lymphocyte count decreased | 398 | 4.6% | 2 | 84 |
| Nausea | 397 | 4.6% | 3 | 51 |
| Drug ineffective | 396 | 4.6% | 1 | 41 |
| Product dose omission issue | 381 | 4.4% | 0 | 86 |
| Covid-19 | 355 | 4.1% | 11 | 123 |
| Urinary tract infection | 352 | 4.1% | 9 | 193 |
| Asthenia | 343 | 4.0% | 4 | 90 |
| Pain | 322 | 3.8% | 0 | 52 |
Other Indications for SIPONIMOD
Multiple sclerosis (3,322)
Product used for unknown indication (2,592)
Secondary progressive multiple sclerosis (2,265)
Relapsing multiple sclerosis (194)
Clinically isolated syndrome (147)
Multiple sclerosis relapse (70)
Primary progressive multiple sclerosis (60)
Progressive multiple sclerosis (20)
Progressive relapsing multiple sclerosis (7)
Other Drugs Used for Relapsing-remitting multiple sclerosis
OCRELIZUMAB (15,658)
FINGOLIMOD (8,814)
OFATUMUMAB (3,864)
DIMETHYL (3,638)
NATALIZUMAB (2,749)
INTERFERON BETA-1A (2,058)
GLATIRAMER (1,965)
ALEMTUZUMAB (1,604)
TERIFLUNOMIDE (1,320)
RITUXIMAB (956)